This analysis shows that despite close concordance to human diseases, and seemingly promising early results, therapies developed from animal studies result in an FDA-approved therapy for humans only about 5% of the time:
Animal studies rarely lead to approvals, new research finds (fiercebiotech.com)
Curing inflammatory gut diseases in cattle or rodents is fine, but I don't start getting my hopes up until I see solid results in humans.
Animal studies rarely lead to approvals, new research finds (fiercebiotech.com)
Curing inflammatory gut diseases in cattle or rodents is fine, but I don't start getting my hopes up until I see solid results in humans.
Last edited: